Toronto
Canada
10
2013-03-21
9
2014-05-27
These are the the leading inventors for applications assigned to APOTEX TECHNOLOGIES INC.:
APOTEX TECHNOLOGIES INC. based in Toronto, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
#2 | 2013-03-07 ✅ Patent 8,507,449 granted on 2013-08-13Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan
#3 | 2013-03-07 ✅ Patent 8,476,235 granted on 2013-07-02Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan
#4 | 2013-02-21 ✅ Patent 8,481,588 granted on 2013-07-09Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#5 | 2013-02-21 ✅ Patent 8,664,262 granted on 2014-03-04Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#6 | 2013-01-03 ✅ Patent 8,592,607 granted on 2013-11-26Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan
#7 | 2012-10-25 ✅ Patent 9,073,865 granted on 2015-07-07Fluorinated derivates of 3-hydroxypyridin-4-ones
#8 | 2012-06-21ORALLY BIOAVAILABLE D-GAMMA-GLUTAMYL-D-TRYPTOPHAN
#9 | 2012-04-19 ✅ Patent 8,673,943 granted on 2014-03-18Fluorinated derivatives of deferiprone
#10 | 2008-10-02 ✅ Patent 8,026,261 granted on 2011-09-27Fluorinated derivatives of deferiprone
Also check out APOTEX TECHNOLOGIES INC.'s (Toronto, Canada) applicant profile with 1 patent applications submitted.
2055 ⎘